Institute of Medical Sciences, Department of Physiology, Kangwon National University School of Medicine, Chuncheon 200-701, South Korea.
Vascul Pharmacol. 2013 Sep-Oct;59(3-4):90-5. doi: 10.1016/j.vph.2013.07.005. Epub 2013 Jul 19.
The effect of efonidipine, a commercially available antihypertensive drug and Ca(2+) channel inhibitor, on voltage-dependent K(+) (Kv) channels was studied in freshly isolated rabbit coronary arterial smooth muscle cells using the whole-cell patch clamp technique. The amplitude of Kv current was decreased by application of efonidipine in a dose-dependent manner, with IC50 of 0.26μM and a Hill coefficient of 0.91, which suggests 1:1 binding stoichiometry. Efonidipine did not affect voltage-dependent activation of the Kv channel, but shifted the inactivation curve by -8.87mV. The inhibitory effect of efonidipine was not significantly changed by depletion of extracellular Ca(2+) or intracellular ATP, which indicated no involvement of the Ca(2+) channel or intracellular protein kinase-dependent cascades. We conclude that efonidipine dose-dependently inhibits Kv current in a phosphorylation- and Ca(2+) channel-independent manner.
研究了市售抗高血压药物和 Ca(2+)通道抑制剂依福地平对新鲜分离的兔冠状动脉平滑肌细胞电压依赖性 K(+)(Kv)通道的影响。采用全细胞膜片钳技术,依福地平以剂量依赖方式降低 Kv 电流幅度,IC50 为 0.26μM,Hill 系数为 0.91,提示 1:1 结合计量比。依福地平不影响 Kv 通道的电压依赖性激活,但使失活曲线向负 8.87mV 移位。细胞外 Ca(2+)或细胞内 ATP 的耗竭对依福地平的抑制作用无明显影响,提示不涉及 Ca(2+)通道或细胞内蛋白激酶依赖级联。我们的结论是,依福地平以不依赖磷酸化和 Ca(2+)通道的方式剂量依赖性地抑制 Kv 电流。